For example, high SOCS2 levels correlate with increased survival in patients with hepatocellular carcinoma (HCC)45,46 and invasive breast cancer47, whereas in metastatic melanoma patients, SOCS2 is a key component of an IFNγ-signature associated with increased survival30. This evidence concerns the gene SOCS2 and metastatic melanoma.